Cronos Group Inc. (TSX: CRON) (NASDAQ: CRON) announced on December 3rd that the company is in fact engaged in discussions with Altria Group Inc. (NYSE: MO). Now, Altria Group has officially agreed to take 45% stake in CRON via the purchase of stock at C$16.25/share.
The value of CRON shares peaked at a 30.42% increase from $8.58 to $11.19 in one hour due to the confirmation announcement on December 3rd. CRON decreased from $11.19 on the 3rd and closed to $10.17 per share. The company’s stock value re-gained an approximate 5.60% in value after market close on December 4th to an overall gain of 25.17%.
Altria Group is likely to be one of several tobacco companies that, in order to compete with falling cigarette usage, could heavily invest into cannabis within the near future. 2017 held the worst year ever recorded for cigarette usage and the total demand for cannabis within the United States is estimated to be at $52.5 billion.
Learn more about other exciting cannabis companies in the Cannin Report. Sign up for Cannin Free Access and subscribe to the Cannin Chronicle. We’ll help you determine which cannabis companies to invest in.